Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

88.10
Delayed Data
As of Mar 24
 +1.15 / +1.32%
Today’s Change
35.37
Today|||52-Week Range
100.40
+42.79%
Year-to-Date
No recent news for bluebird bio Inc.

Today’s Trading

Previous close86.95
Today’s open87.50
Day’s range86.50 - 89.60
Volume518,470
Average volume (3 months)987,870
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-46.99%
Earnings growth (this year)-3.81%
Earnings growth (next 5 years)-39.82%
Revenue growth (last year)-56.28%
P/E ratioNM
Price/Sales373.75
Price/Book4.12

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.48+1.16%
NKTRNektar Therapeutics-0.11-0.49%
TECHBio-Techne Corp+0.32+0.31%
KITEKite Pharma Inc+2.34+3.14%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$1.77
Annual revenue (last year)$6.2M
Annual profit (last year)-$263.5M
Net profit margin-4,281.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs